These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36907464)

  • 1. Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis.
    de A Simoes Moreira D; Gauer LE; Teixeira G; Fonseca da Silva AC; Cavalcanti S; Quevedo J
    J Affect Disord; 2023 Jun; 330():227-238. PubMed ID: 36907464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.
    Rhee TG; Shim SR; Forester BP; Nierenberg AA; McIntyre RS; Papakostas GI; Krystal JH; Sanacora G; Wilkinson ST
    JAMA Psychiatry; 2022 Dec; 79(12):1162-1172. PubMed ID: 36260324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine vs Electroconvulsive Therapy for Major Depressive Episode: A Systematic Review and Meta-analysis.
    Menon V; Varadharajan N; Faheem A; Andrade C
    JAMA Psychiatry; 2023 Jun; 80(6):639-642. PubMed ID: 37043224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine and other glutamate receptor modulators for depression in adults.
    Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and tolerability of different anesthetics in electroconvulsive therapy for major depressive disorder: A systematic review and network meta-analysis.
    Ren L; Yu J; Zeng J; Wei K; Li P; Luo J; Shen Y; Lv F; Min S
    J Psychiatr Res; 2024 Mar; 171():116-125. PubMed ID: 38271762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Ketamine Anesthesia on Efficacy, Tolerability, Seizure Response, and Neurocognitive Outcomes in Electroconvulsive Therapy: A Comprehensive Meta-analysis of Double-Blind Randomized Controlled Trials.
    Ainsworth NJ; Sepehry AA; Vila-Rodriguez F
    J ECT; 2020 Jun; 36(2):94-105. PubMed ID: 31725054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine versus electroconvulsive therapy for major depressive episode: An updated systematic review and non-inferiority meta-analysis.
    Petrucci ABC; Fernandes JVA; Reis IA; da Silva GHS; Recla BMF; de Mendonça JC; Pedro VCS; D'Assunção LEN; Valiengo LDCL
    Psychiatry Res; 2024 Sep; 339():115994. PubMed ID: 38865906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review.
    Memon RI; Naveed S; Faquih AE; Fida A; Abbas N; Chaudhary AMD; Qayyum Z
    Psychiatr Q; 2020 Dec; 91(4):1147-1192. PubMed ID: 32852658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine and electroconvulsive therapy for severe depression: A network meta-analysis of efficacy and safety.
    Liu Y; Yang J; Liu Y
    J Psychiatr Res; 2024 Jul; 175():218-226. PubMed ID: 38744161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Rapid Antidepressant and Antisuicidal Effects of Intramuscular Ketamine, Oral Ketamine, and Electroconvulsive Therapy in Patients With Major Depressive Disorder: A Pilot Study.
    Kheirabadi D; Kheirabadi GR; Mirlohi Z; Tarrahi MJ; Norbaksh A
    J Clin Psychopharmacol; 2020; 40(6):588-593. PubMed ID: 33060432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review.
    Veraart JKE; Smith-Apeldoorn SY; Spaans HP; Kamphuis J; Schoevers RA
    J Affect Disord; 2021 Feb; 281():82-89. PubMed ID: 33307338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine in electroconvulsive therapy for depressive disorder: A systematic review and meta-analysis.
    Ren L; Deng J; Min S; Peng L; Chen Q
    J Psychiatr Res; 2018 Sep; 104():144-156. PubMed ID: 30077114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.
    Daskalakis ZJ; Tamminga C; Throop A; Palmer L; Dimitrova J; Farzan F; Thorpe KE; McClintock SM; Blumberger DM
    Trials; 2021 Nov; 22(1):786. PubMed ID: 34749782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ketamine-assisted electroconvulsive therapy in major depressive episode: a systematic review and network meta-analysis.
    Rhee TG; Shim SR; Popp JH; Trikalinos TA; Rosenheck RA; Kellner CH; Seiner SJ; Espinoza RT; Forester BP; McIntyre RS
    Mol Psychiatry; 2024 Mar; 29(3):750-759. PubMed ID: 38123725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
    Anand A; Mathew SJ; Sanacora G; Murrough JW; Goes FS; Altinay M; Aloysi AS; Asghar-Ali AA; Barnett BS; Chang LC; Collins KA; Costi S; Iqbal S; Jha MK; Krishnan K; Malone DA; Nikayin S; Nissen SE; Ostroff RB; Reti IM; Wilkinson ST; Wolski K; Hu B
    N Engl J Med; 2023 Jun; 388(25):2315-2325. PubMed ID: 37224232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).
    Ekstrand J; Fattah C; Persson M; Cheng T; Nordanskog P; Åkeson J; Tingström A; Lindström MB; Nordenskjöld A; Movahed Rad P
    Int J Neuropsychopharmacol; 2022 May; 25(5):339-349. PubMed ID: 35020871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.